UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X]	QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2015

	OR

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 000-54754

THC Farmaceuticals, Inc.

(f/k/a City Media, Inc.)

(Exact Name of Small Business Issuer as specified in its charter)

UTAH

(State or other Jurisdiction of Incorporation or Organization)

7170 E. McDonald Dr., Ste 3

Scottsdale, Arizona 85253

(Address of principal executive offices)

(480) 725-9060

(Issuer's telephone number, including area code)

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. YES [X] NO [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [X] NO [ ] (The Registrant does not have a corporate Web site.)

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 if the Exchange Act.

Large Accelerated Filer	[ ]		Accelerated Filer	[ ]
Non-accelerated Filer (Do not check if smaller reporting company)	[ ]		Smaller Reporting Company	[X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). YES [ ] NO [X]

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

As of May 8, 2015, 14,996,600 shares of the registrant's common stock were outstanding.

FORWARD LOOKING STATEMENTS

This Quarterly Report on Form 10-Q, Financial Statements and Notes to Financial Statements contains forward-looking statements that discuss, among other things, future expectations and projections regarding future developments, operations and financial conditions. All forward-looking statements are based on management's existing beliefs about present and future events outside of management's control and on assumptions that may prove to be incorrect. If any underlying assumptions prove incorrect, our actual results may vary materially from those anticipated, estimated, projected or intended

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

March 31, 2015

C O N T E N T S

Condensed Consolidated Balance Sheets	3
Condensed Consolidated Statements of Operations	4
Condensed Consolidated Statements of Cash Flows	5
Notes to Condensed Consolidated Financial Statements	6

-2-

THC FARMACEUTICALS, INC.

Condensed Consolidated Balance Sheets

March 31, 2015 and September 30, 2014

(Unaudited)

	03/31/2015			9/30/2014

ASSETS

Current Assets:
Cash	$	586,025		$	637
Accounts Receivable		0			1,754
Total Current Assets		586,025			2,392

Deposits and Prepayments		10,000			0
Property plant & equipment net of accumulated depreciation of $10,072 and $9,472, respectively		12,082			12,082
Intangible Assets		33,677			33,677

TOTAL ASSETS	$	641,784		$	48,150

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities:
Related Party Accounts Payable	$	0		$	900
Accounts Payable		9,275			5,084
Current portion of long term debt - Related Party		0			0
Total Current Liabilities		9,275			5,984
Long Term Liabilities:
Accrued Interest Related Party		0			12,480
Notes Payable to Related Parties		616,368			77,701
Total Long Term Liabilities		616,368			90,181
Total Liabilities		625,643			96,165

Stockholders' Equity/Deficit
Preferred Stock 10,000,000 shares authorized having a par value of $0.001 per share; with no shares issued and outstanding as of March 31, 2015 and September 30, 2014, Respectively		-			-
Common Stock 90,000,000 shares authorized having a par value of $0.001 per share; 11,971,600 issued and outstanding as of March 31, 2015 and 8,968,000 shares issued and outstanding as of September 30, 2014		8,968			8,968
Additional Paid-in Capital		183,875			83,875
Accumulated Deficit		(176,703	)		(140,858	)
Total Stockholders' Equity		16,141			(48,015	)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	641,784		$	48,150

The accompanying notes are an integral part of these condensed consolidated financial statements.

-3-

THC FARMACEUTICALS, INC.

Condensed Consolidated Statements of Operations

For the Three Months and Six Months Ended March 31, 2015 and 2014

(Unaudited)

	For the			For the			For the			For the
	Three Months			Three Months			Six Months			Six Months
	Ended			Ended			Ended			Ended
	March 31,			March 31,			March 31,			March 31,
	2015			2014			2015			2014
Revenues
Revenues from transaction fees	$	5,870		$	4,878		$	10,277		$	9,881
Total Revenues		5,870			4,878			10,277			9,881

Operating Expenses
General and Administrative		10,691			4,036			23,190			17,453
Depreciation		0			148			0			299
Service, related party		4,500			2,700			6,703			6,900
Total Operating Expense		15,191			6,884			29,893			24,652
Operating Loss		(9,321	)		(2,006	)		(19,616	)		(14,771	)
Interest Expense, finance of ATMs		0			16			0			55
Interest Expense, related party		0			1,608			0			2,998
Net Loss	$	(9,321	)	$	(3,630	)	$	(19,616	)	$	(17,824	)
Loss per Common Share - Basic & Diluted	$	(0.01	)	$	(0.01	)	$	(0.01	)	$	(0.01	)
Weighted Average Shares Outstanding - Basic & Diluted		14,971,600			8,968,000			8,968,000			8,968,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

-4-

THC FARMACEUTICALS, INC.

Condensed Consolidated Statements of Cash Flows

For the Six Months Ended March 31, 2015 and 2014

(Unaudited)

	For the			For the
	Six Months			Six Months
	Ended			Ended
	March 31,			March 31,
	2015			2014

Cash Flows From Operating Activities
Net Loss	$	(17,835	)	$	(17,824	)
Adjustments to reconcile net loss to net cash from operating activities:		(203	)
Adjustments to Prepaid Expenses and Other Assets		(10,000	)
Depreciation		151			299
(Increase)/Decrease in accounts receivable		(893	)		(59	)
Increase/(Decrease) in accounts payable		5,286			500
Accrued interest on related party loan		(12,480	)		2,999
Net Cash from Operating Activities		(35,974	)		(15,085	)

Cash Flows from Financing Activities
Principal payments on Notes Payable		0			(1,839	)
Proceeds from notes payable to related parties		621,362			17,100
Net Cash from Investing Activities		621,362			15,261

Net Increase/(Decrease) in Cash		585,388			176
Beginning Cash Balance		637			579
Ending Cash Balance	$	586,025		$	755

Supplemental Disclosure of Cash Flow Information
Cash paid during the period for interest	$	0		$	55
Cash paid during the period for taxes	$	0		$	100
Assets acquired in exchange for related party debt	$	0		$	0

The accompanying notes are an integral part of these condensed consolidated financial statements.

-5-

THC FARMACEUTICALS, INC.

Notes to Condensed Consolidated Financial Statements

March 31, 2015

NOTE 1 - CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at March 31, 2015, and for all periods presented herein, have been made.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2014. The results of operations for the three-month period ended March 31, 2015 are not necessarily indicative of the operating results for the full year.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Recent Accounting Pronouncements

The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its condensed consolidated financial statements.

NOTE 3 – RELATED PARTY TRANSACTIONS / SERVICE AGREEMENT

The Company has a Service Agreement with Wasatch ATM ("Wasatch"), a Utah limited liability corporation owned and managed by a Company stockholder. The agreement provides for Wasatch to provide all maintenance, repair and service work along with distribution of vault cash. Since December 1, 2014, Wasatch has been compensated at a rate of $1,500 per month. The fee paid to Wasatch may be subject to change.

NOTE 4 - RELATED PARTY TRANSACTIONS / LONG-TERM DEBT

For the quarter ending September 30, 2014, the Company owed $77,701 in related party long-term debt and $12,480 in related party accrued interest. During the quarter ending December 31, 2014, these amounts were paid in full by the Company as part of the change of control transaction and a new loan of $5,000 was made by a related party. On March 31, 2015, the Company owed $616,368 in related party long-term debt and no related party accrued interest.

NOTE 5 - SUBSEQUENT EVENTS

On April 3, 2015, Patrick Bilton resigned as a director as discussed in our previously filed 8-K, incorporated as Exhibit 2.4 by reference.

-6-

ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION.

When used in this Annual Report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," and similar expressions are intended to identify forward-looking statements regarding events, conditions, and financial trends that may affect Guide's future plans of operations, business strategy, operating results, and financial position. Persons reviewing this Annual Report are cautioned that any forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties and actual results may differ materially from those included within the forward-looking statements as a result of various factors. Such factors are discussed further below under "Trends and Uncertainties," and also include general economic factors and conditions that may directly or indirectly impact our financial condition or results of operations.

On February 15, 2015, we filed amended articles of incorporation with the Secretary of State of Utah changing our name from City Media, Inc. to THC Farmaceuticals, Inc. Our trading symbol is CBDG.

Plan of Operation

Our primary focus for during 2014 was the placement and servicing of ATM machines for public use along the Wasatch Front in the State of Utah. During the quarter ended March 31, 2015, we had a total of nine machines in operation and all nine machines remain in operation as of the quarter ended March 31, 2015. Management is researching the feasibility of new means and/or technologies to facilitate the legal sale of industrial hemp, medical marijuana and/or legal recreational marijuana. In this regard, we are seeking to implement a feasible plan to utilize the hempcoin assets the Company acquired in December 2014. Additionally, the Company plans to expand into related additional areas they believe would be profitable for the Company and benefit its shareholders. One such area is the cultivation and sale of industrial hemp.

The Company has also acquired hemp related patents or patent rights and minority ownership of LVCIC, a cannabis information center in Las Vegas, Nevada.

Presently, the Company does not have sufficient funds, without additional equity or debt financing to support operations for the next fiscal year. There is presently no commitment to provide any further funding to the Company. Given our current lack of liquidity and difficulty in obtaining debt from traditional banking sources, we will focus future fund raising on the sale of our equity securities. There can be no assurance that we will be successful at raising additional capital and without additional capital, we will not be able to expand operations and reach long term profitability.

Results of Operations

Three Months Ended March 31, 2015 Compared to Three Months Ended March 31, 2014

During the three months ended March 31, 2015, we recognized $5,870 in revenues. During the three months ended March 31, 2014, we recognized $4,878 in revenues. The increase in revenue for the period ended 2015 over the same period in 2014 appears to be attributable to an increase in consumer demand for cash transactions created by an improving economy and tourism industry in Utah.

We had a net loss for the three months ended March 31, 2015, of $9,321 and a net loss of $3,630 for the three months ended March 31, 2014. The loss for the quarter ended March 31, 2015 was more than the loss which occurred during the same quarter in 2014, primarily due to increases in general and administrative expenses during the quarter ended March 31, 2015 from planning and consulting activities.

-7-

We will need additional capital to expand operations and anticipate seeking both debt and equity capital in 2015. Additionally, as our business operations are only beginning, it is difficult to predict our ability to generate sufficient revenue to generate positive cash flows. Currently our biggest expenses are related to general and administrative costs consisting mainly of accounting and legal fees, which were $10,691 for the three months ended March 31, 2015 and $4,036 for the three months ended March 31, 2014. Our service fee to maintain ATM cash levels and operating functionality is $1,500 per month. We anticipate these fees remaining constant during 2015; however, they may rise in the future if we deploy more machines.

Six Months Ended March 31, 2015 Compared to Six Months Ended March 31, 2014

During the six months ended March 31, 2015, we recognized $10,277 in revenues. During the six months ended March 31, 2014, we recognized $9,881 in revenues. The nominal increase in revenue for the period ended 2015 over the same period in 2014 can be attributed to increased demand for cash transactions in the last fiscal quarter as described above.

We had a net loss for the six months ended March 31, 2015, of $19,626 and a net loss of $17,824 for the six months ended March 31, 2014. Our net loss for the 2015 period was the result of costs of service for maintaining our ATM machines, as well as general and administrative expenses.

Liquidity and Capital Resources

We had $586,025 cash or cash equivalents on hand as of March 31, 2015. However, $575,000 of that amount was a short-term intercompany transfer from Weed Growth Fund, Inc., the Company's largest shareholder, and that amount was returned to Weed Growth Fund, Inc. on April 16, 2015 at which point the cash balance was $12,861.

For the quarter ending March 31, 2015, the Company owed $616,368 to its parent company, Weed Growth Fund, Inc. for loans made to the Company.

The Company has accumulated losses of $176,703. As previously discussed above, management's plans include a review of the ATM business model and the addition of new business units in order to improve our cash flows and profitability. The Company does anticipate receiving loan commitments from shareholders to sufficient fund operations for the next 12 months.

Off-Balance Sheet Arrangements

We had no Off-Balance Sheet arrangements during the quarter ended March 31, 2015.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including the Principal Executive Officer and Principal Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based on that evaluation, the Principal Executive Officer and Principal Financial Officer have concluded that these disclosure controls and procedures are effective.

-8-

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting during the quarter ended March 31, 2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

None.

ITEM 1A. RISK FACTORS.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 2. UNREGISTERED SALE OF EQUITY SECURITIES.

We issued 3,000,000 shares its common stock to David Tobias during the quarter ended March 31, 2015, pursuant to our agreement with Mr. Tobias dated January 5, 2015 and filed as Exhibit 10.2 to our Form 8-K filed with the SEC on January 6, 2015.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

None.

ITEM 5. OTHER INFORMATION.

None.

-9-

ITEM 6. EXHIBITS.

The following documents are included herein:

Exhibit		Incorporated by reference			Filed
Number	Document Description	Form	Date	Number	herewith
2.1	Articles of Incorporation, as amended	S-1	12/30/10	2.1

2.2	Bylaws	S-1	12/30/10	2.2

2.3	Agreement and Plan of Merger	S-1	12/30/10	2.3

2.4	Articles of Amendment	8-K	03/19/15	2.4

10.1	Stock Purchase Agreement	10-K	11/18/14	10.1

10.2	Lock Up Agreement	8-K	11/20/14	10.2

10.3	Securities Purchase Agreement with Las Vegas Cannabis Info Center	8-K	01/06/15	10.1

10.4	Asset Purchase Agreement with David Tobias	8-K	01/06/15	10.2

21.1	List of Subsidiaries	S-1	12/30/10	21.1

31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				X

31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				X

32.1	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for the Chief Executive Officer				X

32.2	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for the Chief Financial Officer				X

101.INS	XBRL Instance Document				X

101.SCH	XBRL Taxonomy Extension – Schema				X

101.CAL	XBRL Taxonomy Extension – Calculations				X

101.DEF	XBRL Taxonomy Extension – Definitions				X

101.LAB	XBRL Taxonomy Extension – Labels				X

101.PRE	XBRL Taxonomy Extension – Presentation				X

-10-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following person on behalf of the Registrant and in the capacities on this 15^th day of May, 2015.

	THC FARMACEUTICALS, INC.

	BY:	ERIC MILLER
		Eric Miller
		President, Principal Executive Officer and Director

	BY:	JON McGEE
		Jon McGee
		Principal Financial Officer, Principal Accounting Officer, Treasurer and Director

-11-

EXHIBIT INDEX

Exhibit		Incorporated by reference			Filed
Number	Document Description	Form	Date	Number	herewith
2.1	Articles of Incorporation, as amended	S-1	12/30/10	2.1

2.2	Bylaws	S-1	12/30/10	2.2

2.3	Agreement and Plan of Merger	S-1	12/30/10	2.3

10.1	Stock Purchase Agreement	10-K	11/18/14	10.1

10.2	Lock Up Agreement	8-K	11/20/14	10.2

10.3	Securities Purchase Agreement with Las Vegas Cannabis Info Center	8-K	01/06/15	10.1

10.4	Asset Purchase Agreement with David Tobias	8-K	01/06/15	10.2

21.1	List of Subsidiaries	S-1	12/30/10	21.1

31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				X

31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				X

32.1	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for the Chief Executive Officer				X

32.2	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for the Chief Financial Officer				X

101.INS	XBRL Instance Document				X

101.SCH	XBRL Taxonomy Extension – Schema				X

101.CAL	XBRL Taxonomy Extension – Calculations				X

101.DEF	XBRL Taxonomy Extension – Definitions				X

101.LAB	XBRL Taxonomy Extension – Labels				X

101.PRE	XBRL Taxonomy Extension – Presentation				X

-12-

THC Farmaceuticals, Inc. 10-Q